<DOC>
	<DOC>NCT02084927</DOC>
	<brief_summary>The aim of the current study is to evaluate, in a prospective cross-over, randomized study, the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological deficits and cognitive impairment after anterior skull base meningioma tumor removal.</brief_summary>
	<brief_title>Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Meningioma</mesh_term>
	<mesh_term>Neurologic Manifestations</mesh_term>
	<criteria>Post intracranial meningioma removal surgery 312 months prior to the inclusion in the study. All patients have to have persistent cognitive or neurological complaints regarding without noticeable improvement during the last month prior to their enrolment. Age 18 years or older. Dynamic neurologic/cognitive improvement or worsening during the past month; Evidence of dynamic cognitive/neurological improvement in the last month. Previous brain radiotherapy and/or radiosurgery. Steroids dependence Seizures 1 month previous to inclusion Had been treated with HBOT for any other reason 1 month prior to inclusion; Have any other indication for HBOT; Chest pathology incompatible with pressure changes; Inner ear disease; Patients suffering from claustrophobia; Inability to sign written informed consent; Smoking patients will not be allowed to smoke during the study and if they would not comply with this demand they will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>